The repository is currently being upgraded to DSpace 7. Temporarily, only admins can login. Submission of items and changes to existing items is prohibited until the completion of this upgrade process.
Expression of a novel follicle stimulating hormone glycoform
Abstract
Heterodimeric pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating
hormone (FSH), play significant roles in follicular development and maintenance of the female
reproductive cycle. FSH functions in the ovary include: stimulation of follicle growth, estradiol
synthesis and selection of dominant follicles. FSH exists as two glycoforms, designated di- and
tetra-glycosylated FSH. Di-glycosylated FSH contains 2 carbohydrates located only on the α
subunit, while tetra-glycosylated FSH has 4 carbohydrates, 2 each on the α and β subunits.
Individual pituitary FSH analysis shows that in young, reproductive-age women, di-glycosylated
FSH is more abundant than tetra-glycosylated FSH, whereas in postmenopausal women there is
more pituitary tetra-glycosylated FSH. In vitro bioassay of di-glycosylated FSH shows that it has
significantly greater biological activity than tetra-glycosylated FSH. As the availability of diglycosylated
human FSH from natural or mammalian-generated recombinant sources is limited,
bacterial expression of recombinant human FSHβ (rec hFSHβ) was explored as an avenue to
provide sufficient di-glycosylated hFSH for structural and biological function studies. We chose
the E.coli Origami expression system to make non-glycosylated FSHβ because it lacks the
ability to N-glycosylate the wild-type protein sequence. The wild-type hFSHβ sequence is
desired because mutations to eliminate N-glycosylation are known to reduce expression
efficiency. Moreover, mutations to silence the Asn24 glycosylation site, appear to affect protein
folding and stability. Bacterially expressed hFSHβ was extracted and separated into soluble and
insoluble fractions. We obtained a relatively pure (>90%) hFSHβ preparation derived from the
insoluble fraction, which had to be refolded. We also recovered a small quantity of apparently
partially folded hFSHβ in the soluble fraction after Affi-Gel Blue purification. The attempts to fold denatured insoluble fraction hFSHβ were unsuccessful, as we could not get the folding
reaction product to associate with α subunit and constitute a functional hormone. Furthermore,
the soluble fraction, assumed to be folded, because it bound to Affi-Gel Blue via dye
intercalation between cystine knot loops 1 and 3, also failed to associate with α subunit. Overall,
we could not use a bacterial expression system to make a functional hFSHβ to combine with the
α subunit to make a functional intact hormone. Moreover, the electrophoretic mobility of the
12.5 kDa bacterially expressed hFSHβ reflected the formula weight of the primary sequence
more closely than that of the 21 kDa non-glycosylated pituitary hFSHβ, suggesting unknown
posttranslational modification of the 21 kDa form. However, upon further investigation, the 12.5
kDa band appeared to be a fragment, rather than a full-length subunit. This result rationalizes the
failure to fold, as fragments do not fold.
Description
Thesis (M.S.)--Wichita State University, College of Liberal Arts and Sciences, Dept. of Biological Sciences.